This review briefly describes the nuclear characteristics and production parameters for 7.2-h 211At, 60.6-min 212Bil 45.6-min 213Bi, 1 1 d 233Ra, and 20-h 255Fm. These a-emitting radioisotopes are the subject of current interest for a-partide-mediated radioimmunotherapy.
Introduction
Alpha particles are of considerable interest for radioimmunotherapy applications. Due to their short range in tissue (a few cell diameters), and high linear-energy-transfer (LET), a-particles are especially suited for targeting micrometatases and single tumor cells such as leukemia and other blood-borne diseases (Bloomer et a/., 1984, Ruegg, et a/., 1990, Huneke, et a/., 1992, Junghans, et a/., 1993, Hartmann, et a/., 1994 , Kennel and Mirzadeh, 1997 , Scheinberg, 1997 . The list of potential radionuclides for these applications includes only five a-emitting radioisotopes, namely 211At (tIQ = 7.2 h), 212Bi (t1,2 = 60.6 m), 213Bi (tlQ = 45.6 m), 233Ra ( t l M = 11 d), and 255Fm (tln Table 1 . The nuclear decay characteristics of 211Atl 212Bi, 213Bi, 233Ra and 255Fm are summarized in (Kennel and Mitzadeh, 1997) .
21'Rn(14.6 h) + *"At(7.2 h). Astatine-211 can be produced through the decay of 14.6 h 211Rn. The 21'Rn, in turn, is produced through a number of nuclear reactions which are summarized in Table 3 . The corresponding references are also given in this table. These reactions include spallation of Th with high energy protons having a cross-section of 0.7 mb at 28 GeV protons or by photo-spallation of Th with a cross-section of 0.13 mb at a photon energy of 300 MeV. The production of 2'1Rn by the 209BitLi14n]211Rn reaction, with a amax = 0.7 b at E , = 54 MeV and yield of -2 pCi/nA at '/z saturation, has also been reported. By far, the predominant nuclear reaction for the production of 211Atl however, is not through a generator system but by direct activation of 209Bi
with 28 MeV u particles, The maximum of the excitation function for this reaction is -1 b at E , = 29
MeV. In order to minimize the production of radiocontaminant 210Po, the a-particle should exit the Bi target at E , = 20 MeV, limiting the Bi thickness to only 100 pg.cm-*. The typical yield is -1.5 mCi/pA at half saturation (-3.5 hours of irradiation). Since there are only a few cyclotrons in the U.S. capable of accelerating a-particles to -28 MeV, the required energy for the production of 211At via the 209Bi [a,2n] reaction, the availability of 211At is also very limited. There are a number of procedures reported for extracting 21'At from an irradiated Bi target, and a recent review of the subject is available (Ruth et al, 1988) . The dry distillation method is the most convenient approach and it has been described in detail elsewhere (Lambrecht and Mirzadeh, 1985) .
224Raf3.7 d) -* 212Pbf10.6 h) .--* 2'2Bi(60.6 minl. Bismuth-212 is available from the 224Ra/212Bi
generator system, where 224Ra is the daughter of 1.9-y =%I . Th-228 is the second member of the 232Th decay chain and it is also the decay product of 232U (Fig. la) . Ra-228 (tin = 5.8 y) can be extracted from 232Th, purified, then allowed to decay to 22&rh. Each ton of 30-year old 232Th yields -100 mCi of 228Ra. Th-228, however, can be produced from successive neutron capture and f3-decay of 226Ra (Fig.2) . This irradiation has been demonstrated in the past to be feasible. However, additional process development is needed to determine production yields and cost. Figure 3 depicts the theoretical production yields of both 22&Th and =?h at the ORNL High Flux Isotope Reactor (HFIR) as a function of irradiation time at a neutron flux of IxlOq5 n.s'1.cm'2. For one cycle irradiation (-24 days), the yield of =&rh is -45 mg (37 Ci) per gram of =*Ra. The major drawback for the use of 212Bi is the emission of relatively intense and very high energy prays (2.6 MeV, 38%).
In the current generator system, 224Ra separated from 22&n) is adsorbed on an organic cation exchange resin (highly cross-linked MP-50, -300 pL in volume), and the 212Pb and 212Bi mixture is eluted with a few mL of 2 HCI or 0.5 & l HI with -70% yield and parent breakthrough of lo4. It is also possible to elute 212Bi (free from 212Pb) selectively with 0.5 HI. The 224Ra/212Pb/212Bi generator has a shelf-life of about two weeks, and 10-mCi generators are routinely available from Argonne National Laboratory (ANL).
Unfortunately, radiolytic effects limit the scale of the current organic resin-based (Kennel and Mirzadeh, 1997) . Bismuth-213 decays with a t , , of 45.6 min and emits an 8.4 MeV a-particle 97.8% of the time. The decay of 213Bi follows with the emission of rather low intensity prays; 440 keV (26%) and 1566 keV (2%).
Similar to the 224Ra + 212Bi pathway, carrier-free 213Bi is available from the 225Ad213Bi generator system with 225Ac ( t i , = Th-228 can also be produced from neutron transmutation of a 226Ra target (Fig. 2) . The yield of =*h is on the order of 7 mg (-150 mCi) per g of 226Ra for 24 days irradiation at a neutron flux of lxlOI5 n.s-1.cm-2, with a thermal to epithermal ratio of 10 (Fig. 3) . Note that under these conditions, the mass of the contaminant z% produced is -4 times larger than that of 22vh (the activity ratio is 250). Nevertheless, high purity "5Ac can be obtained from the mixture by initially extracting Ra from Th and allowing the 3.7d 224Ra to decay (10-15 days) then extracting 225Ac from the Ra mixture. Note that the 224Ra adecays to 220Rn with no B-decay to 224Ac.
It is also possible to produce 225Ac from proton and deuteron irradiation of 226Ra, [p,2n] and [d,n] reactions (see Fig. 2 ). The author is not aware of any reported excitation functions for these reactions.
Although 233U is the only viable source for high purity 22%, the anticipated difficulty with 233U safeguards led us to look at the possibility of extracting Th from pre-existing processing waste of 233U. After extensive purification, -65 mCi of low specific activity (-0.4%) 22?h has been recovered and 20 mCi of 225Ac is available for sale through the ORNL Isotope Distribution Office on a bi-weekly schedule.
The chemistry of the z5Ac/213Bi generator is also similar to that described for the 212Bi generator. However, the lower cross-linked resin was found to be more suitable for rapid elution of 213Bi from the generator with 225Ac breakthrough of 4%. A summary of the 213Bi yield and 225Ac
and 225Ra breakthrough values are given in Table 4 (Boll and Mirzadeh, 1997). As indicated in the last column, the breakthrough of Ra in AG 5 0 W 4 resin was substantially higher than Ac breakthrough. Thus it follows that in order to reduce the potential contamination of 213Bi with Ra, the Ac generator-load solution should contain a low fraction of Ra. At the 2-3 mCi level, the radiolytic degradation of organic resin limits the useful shelf-life of a generator to about one week.
227Th(18.7 d) -+ 223Ra(11.4 d).
The 227Th/223Ra system is a part of the actinium series and 227Th is produced from 8' of 21-y 227Ac. The 227Ac can be extracted from 235U or it can be produced by irradiation of 226Ra target in a reactor by the 226Ra[n,y]227Ra (K, 42 min) -227Ac reaction (Fig. 2) . The irradiation route has high yield and eliminates the problem associated with the 235U safeguards (Fig. 3) . There are, however, two major difficulties with 223Ra. The first is the lack of suitable chelating molecule for attachment of 233Ra to monoclonal antibodies. The second concern is with the decay characteristic of this isotope. As indicated in Table 2 , the third decay product of 233Ra is the ' "Pb which has a half-life of 36 minutes. The kinetic energy imparted to 211Pb due to aemission ejects the '"Pb atom from the original carrier molecule and leaves the 2"Pb atom highly charged and reactive (Minadeh, 1993) . A portion of unbound 211Pb, having sufficient time t-re-enter the blood stream, results in a substantial dose to the non-targeted tissues.
Note that 21'Pb is a highly potent a-emitter as well (see Fig. IC ). 255E~, a transuranium radioisotope) has the most convenient half-life, but it is doubtful that useful quantities of this radioisotope will be made available within the foreseeable future.
255Es(40 d
In summary, methods have been demonstrated for large scale production of emitters for medical applications with the exception of 255Fm. Over the next few years, it i s expected that clinical generators for in-house production of the short-lived 212Bi and 213Bi will be made available. Reactor production of 227Ac, 228Th and 22%h from 226Ra target.
Theoretical production yields of 227Ac, 22&Th and 229h from 1 g of 226Ra as a function of irradiation time at a neutron flux of lx1015 n.s''.cm'2, (th/epi=lO). Table 1 .
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